시장보고서

상품코드

1713223

제약용 멤브레인 필터 시장 규모 및 예측(2021-2031년) : 세계 및 지역 점유율, 동향, 성장 기회 - 분석 범위(기술별, 설계별, 재료별, 최종사용자별, 지역별)

Pharmaceutical Membrane Filters Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology, Design, Material, End User, and Geography

발행일: 2025년 03월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 224 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

제약용 멤브레인 필터 시장은 2024년 84억 7,000만 달러로 평가되며 2031년에는 200억 5,000만 달러에 달할 것으로 예상되며, 2025년부터 2031년까지 13.0%의 CAGR을 기록할 것으로 예상됩니다. 시장 성장을 촉진하는 주요 요인으로는 바이오의약품 수요 증가, 엄격한 규제 요건 및 품질 등이 있습니다.

제약용 멤브레인 필터 시장은 제약에 사용되는 멤브레인 기반 여과 기술에 초점을 맞춘 세계 산업을 말합니다. 이러한 필터는 멸균, 오염 제어, 제품 정제 공정에 도움이 되며, 의약품의 안전과 규제 준수를 보장합니다.

북미 제약용 멤브레인 필터 시장은 미국, 캐나다, 멕시코로 구분됩니다. 북미는 시장 성장을 견인하는 데 매우 중요한 역할을 할 것으로 예상됩니다. 미국, 캐나다, 멕시코로 구성된 북미는 엄격한 규제, 생물학적 제제 수요 증가, 제조업의 확대로 인해 제약용 멤브레인 필터 시장에서 큰 성장을 이루고 있습니다. 미국은 바이오테크놀러지의 발전, 캐나다는 R&D 투자 증가, 멕시코는 의약품 아웃소싱의 증가로 이익을 얻고 있으며, 이는 시장 확대를 주도하고 있습니다.

북미에서는 미국이 제약용 멤브레인 필터 시장에서 가장 높은 점유율을 차지하고 있습니다. 미국의 제약용 멤브레인 필터 시장은 제약 및 바이오의약품 생산 증가, 무균 여과에 대한 엄격한 규제 지침, 고순도 여과 솔루션에 대한 수요 증가로 인해 강력한 성장세를 보이고 있습니다. 바이오테크 기업이 존재하며, CRO(임상시험수탁기관) 분야에서도 약 4,321개 기업이 미국에서 사업을 전개하고 있습니다.

멤브레인 필터는 생물학적 제제 및 바이오시밀러의 무균성을 보장하고, 미립자를 제거하며, 약품 품질을 향상시키는 데 중요한 역할을 합니다. 첨단 고분자막의 개발, 나노 여과 및 한외 여과 기술 혁신 등 기술 발전은 이러한 필터의 채택에 박차를 가하고 있습니다. 엄격한 FDA 규제와 USP 표준으로 인해 의약품 제조는 고성능 여과 기술을 채택해야 하며, 멸균, 정밀여과, 바이러스 제거 등의 용도로 멤브레인 필터에 대한 수요가 증가하고 있습니다. 바이오 공정에서 일회용 기술에 대한 중요성이 높아짐에 따라 일회용 여과 시스템의 채택을 촉진하고, 2차 오염의 위험을 줄여 업무 효율성을 높이고 있습니다. 만성질환의 증가와 이에 따른 의약품 개발 활동, 특히 단클론항체, 백신, 재조합 단백질의 급격한 증가는 멤브레인 필터의 소비 확대에 기여하고 있습니다. 예를 들어, CDC의 분기별 잠정 사망률 추정에 따르면 심장병과 암은 여전히 주요 사망 원인으로 2024년 2분기까지 12개월 동안 심장병의 연령 조정 사망률은 인구 10만 명당 168.5명, 암은 146.2명이었습니다.

Merck Millipore, Sartorius AG, Danaher Corporation과 같은 주요 기업들은 필터 성능 향상, 처리량 증가, 진화하는 업계 표준 준수를 위한 연구개발에 지속적으로 투자하고 있습니다. 제약회사와 여과 기술 제공업체와의 전략적 제휴를 통해 기술 혁신을 촉진하고 특정 제형에 맞는 맞춤형 여과 솔루션을 개발할 수 있게 되었으며, COVID-19 팬데믹은 백신 및 치료제 생산에 있어 제약 멤브레인 필터의 중요한 역할을 강조하고 있습니다. 부각시켰습니다. 제약 분야에서 연속 생산 공정의 채택이 증가함에 따라 일관된 제품 품질과 확장성을 보장하는 고효율 멤브레인 여과 시스템에 대한 수요도 증가하고 있습니다.

제약 및 생명공학 산업에 대한 정부 및 민간 투자의 증가는 고성능 여과 기술의 채택을 촉진하고 있습니다. 예를 들어, 2023 회계연도에 국립보건원(NIH)은 약 477억 달러의 예산을 받았으며, 그 중 공중보건국(PHS)의 평가 융자 14억 1,200만 달러, 1형 당뇨병 특별회계의 의무 자금 1억 4,150만 달러, 21세기 치료법에서 배정받은 10억 8,500만 달러입니다.

미국 내 바이오의약품 연구의 확대와 임상시험의 증가는 특히 무균 여과 및 세포배양 응용 분야에서 멤브레인 필터에 대한 수요를 유지할 것으로 예상됩니다. 또한, 지속가능성과 친환경 여과 기술에 대한 관심이 높아짐에 따라 제조업체들은 에너지 효율이 높고 재활용 가능한 막 여과 제품을 개발하기 위해 노력하고 있습니다.

의료용 케이블 설계의 발전은 향후 시장 동향을 가져올 것입니다.

신흥 시장, 특히 인도와 중국의 제약 산업은 빠르게 성장하고 있으며, 이들 국가는 세계 의약품 제조 기지로 변모하고 있습니다. 비용 효율적인 생산, 숙련된 노동력, 유리한 정부 정책, 국내 수요 확대와 같은 경쟁 우위가 대규모 의약품 생산에 박차를 가하고 있습니다. 그 결과, 의약품의 순도, 규제 준수 및 제조 효율을 보장하는 첨단 막 여과 시스템에 대한 수요가 급증하고 있습니다.

'세계의 약국'으로 불리는 인도는 전 세계 제네릭 의약품의 20% 이상을 공급하고 있으며, 3,000개 이상의 제약회사와 10,500개 이상의 제조시설을 보유하고 있고, 대부분 미국 FDA 및 EMA와 같은 국제 규제 기준을 준수하는 등 세계 공급망에서 중요한 역할을 담당하고 있습니다. 한편, 중국은 정부의 강력한 지원과 의약품 제조 공정을 간소화하는 제조판매업자(MAH) 제도와 같은 규제 개혁을 통해 바이오의약품 및 원료의약품(API) 분야에서 큰 진전을 이루고 있습니다. 양국은 의약품 수출을 지속적으로 확대하고 있으며, 세계 안전 및 품질 기준을 준수하기 위해 고품질 여과 기술에 대한 수요가 증가하고 있습니다.

이러한 시장에서는 제조 비용이 중요하기 때문에 제약 회사들은 효율성과 경제성 사이에서 균형을 이루는 멤브레인 여과 솔루션을 찾고 있습니다. 이에 따라 재사용 또는 일회용 멤브레인, 에너지 효율적인 설계, 고처리량 여과 기술을 통해 제조 비용을 최적화하고, 고성능 및 확장 가능한 여과 시스템의 채택이 증가하고 있습니다. 인도의 생산 연동 장려금(PLI) 제도와 중국의 메이드 인 차이나 2025 전략과 같은 정부 이니셔티브는 의약품 자급자족을 지원하고 첨단 제조 역량에 대한 투자를 촉진하고 있습니다. 미국과 유럽과 같이 규제가 엄격한 시장으로의 수출이 증가함에 따라 인도와 중국의 제약회사들은 엄격한 여과 기준을 충족해야 하기 때문에 최첨단 막여과 솔루션에 대한 수요가 더욱 증가하고 있습니다. 이들 신흥국에서의 의약품 제조의 장기적인 성장은 헬스케어 수요 증가, 정부 인센티브, 바이오시밀러 및 맞춤 의료의 부상 등에 힘입어 여과 기술에 대한 높은 수요를 유지할 것으로 예상됩니다. 지속가능성 또한 우선순위로 떠오르면서 기업들은 폐기물을 줄이고, 에너지 소비를 줄이며, 운영 효율성을 향상시키는 친환경 여과 시스템으로 전환하고 있습니다.

인도와 중국이 세계 제약 강국으로서의 입지를 굳히면서 첨단 멤브레인 여과 기술이 의약품의 안전성, 품질 및 비용 효율성을 보장하는 데 중요한 역할을 하게 되었고, 이는 국내외 멤브레인 필터 제조업체가 고성장 시장에서 사업을 확장할 수 있는 좋은 기회로 작용하고 있습니다.

업계 동향의 일부를 소개합니다:

인도 정부는 국내 의약품 제조를 강화하기 위해 의약품 및 의료기기 PLI 계획에 30억 달러에 가까운 자금을 배정했습니다. 이 계획은 2024년 4월 현재 약 40억 달러의 투자 유치에 성공했습니다.

약 580억 달러로 추정되는 인도의 제약 부문은 2030년까지 1,200-1,300억 달러, 2047년까지 4,000-4,500억 달러에 달할 것으로 예상됩니다. 이러한 성장의 원동력은 생활습관병의 증가, 고령화, 전인적 건강 지향의 증가 등의 요인에 기인합니다.

2022년부터 2025년까지 유럽과 미국의 제약회사들은 혁신적인 '슈퍼 미투' 의약품을 얻기 위해 중국 기업과의 제휴를 늘리고 있으며, GSK, 머크, 아스트라제네카 등 대형 제약회사들은 중국의 신속한 임상시험 프로세스를 활용하여 중국 의약품을 국제적으로 개발 및 판매하기 위해 중국 의약품을 국제적으로 개발 및 판매하기 위해 10억 달러 규모의 계약을 체결했습니다.

2023년 중국과 인도는 전년 대비 1.5% 증가한 1,362억 달러의 기록적인 양국 간 무역액을 달성했습니다. 이러한 성장을 뒷받침한 것은 인도의 대중국 수출이 6% 증가하여 양국의 경제적 유대가 강화되고 있음을 보여줍니다.

세계보건기구(WHO), 보건부(National Health of Health), 경제협력개발기구(Organization for Economic Co-operation and Development) 등은 의료용 사출 성형 시장 보고서를 작성할 때 참고한 1차 정보 및 2차 정보 중 하나입니다.

제약용 멤브레인 필터 시장 : 주요 시장 역학
시장 성장 촉진요인
- 바이오의약품 수요 증가
- 엄격한 규제 요건과 품질 보증
시장 성장 억제요인
- 높은 초기 비용과 운영 비용
시장 기회
- 막 여과 기술 진보
향후 동향
- 의료용 케이블 설계의 진보
성장 촉진요인과 억제요인의 영향

제6장 제약용 멤브레인 필터 시장 : 세계 시장 분석

제약용 멤브레인 필터 시장 매출(2021-2031년)
제약용 멤브레인 필터 시장 예측과 분석

제7장 제약용 멤브레인 필터 시장 분석 : 기술별

정밀여과
한외여과
역삼투
나노여과

제8장 제약용 멤브레인 필터 시장 분석 : 설계별

중공사
나선형
관형 시스템
플레이트형·프레임형

제9장 제약용 멤브레인 필터 시장 분석 : 재료별

폴리에테르설폰(PES)
폴리설폰(PS)
셀룰로오스계 멤브레인
폴리테트라플루오로에틸렌(PTFE)
폴리염화비닐(PVC)
폴리아크릴로니트릴(PAN)
기타

제10장 제약용 멤브레인 필터 시장 분석 : 최종사용자별

제약·바이오테크놀러지 산업
CRO·CDMO

제11장 제약용 멤브레인 필터 시장 : 지역별 분석

북미
- 미국
- 캐나다
- 멕시코
유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 중국
- 일본
- 인도
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 기타 중동 및 아프리카
중남미
- 브라질
- 아르헨티나
- 기타 중남미

제12장 업계 상황

사업 확대
협업
기업 인수합병(M&A)
파트너십
기타 사업 전략

제13장 기업 개요

Thermo Fisher Scientific Inc
Merck KGaA
Danaher Corporation
3M
Sartorius AG
Repligen Corporation
Parker Hannifin Corporation
Asahi Kasei Corporation
GEA Group
Alfa Laval
TAMI Industries
Membrane Solutions
Koch Industries
W L Gore and Associates Inc
Meissner Filtration Products, Inc.

제14장 부록

ksm 25.05.14

The Pharmaceutical Membrane Filters market was valued at US$ 8.47 billion in 2024 and is projected to reach US$ 20.05 billion by 2031; it is expected to register a CAGR of 13.0% from 2025 to 2031. Major factors driving the market growth include the increasing demand for biopharmaceuticals and stringent regulatory requirements and quality.

The Pharmaceutical Membrane Filters Market refers to the global industry focused on membrane-based filtration technologies used in pharmaceutical manufacturing. These filters help in sterilization, contamination control, and product purification processes, ensuring drug safety and regulatory compliance.

The pharmaceutical membrane filters market in North America is segmented into the US, Canada, and Mexico. The North American region is anticipated to play a pivotal role in driving the market's growth. North America, comprising the U.S., Canada, and Mexico, is witnessing significant growth in the pharma membrane filter market due to stringent regulations, rising biologics demand, and expanding manufacturing. The U.S. leads with biotech advancements, Canada sees increased R&D investments, and Mexico benefits from growing pharmaceutical outsourcing, collectively driving market expansion.

In North America, the US holds the highest share of the pharmaceutical membrane filters market. The US pharmaceutical membrane filters market is witnessing robust growth driven by increasing pharmaceutical and biopharmaceutical production, stringent regulatory guidelines for sterile filtration, and rising demand for high-purity filtration solutions. As per Ibis World, in 2024, the United States was home to approximately 2,432 biotechnology companies; likewise, in the contract research organization (CRO) sector, about 4,321 businesses are operating in the US.

Membrane filters play a critical role in ensuring sterility, removing particulates, and improving the drug quality of biologics and biosimilars. Technological advancements, including the development of advanced polymeric membranes and innovations in nanofiltration and ultrafiltration, are fueling the adoption of these filters. Stringent FDA regulations and USP standards necessitate the adoption of high-performance filtration technologies in drug manufacturing, thereby boosting demand for membrane filters across applications such as sterilization, microfiltration, and virus removal. The growing emphasis on single-use technologies in bioprocessing is driving the adoption of disposable filtration systems, reducing the risk of cross-contamination and enhancing operational efficiency. The rising prevalence of chronic diseases and the subsequent surge in drug development activities, particularly in monoclonal antibodies, vaccines, and recombinant proteins, are contributing to increased consumption of membrane filters. For instance, according to the CDC's Quarterly Provisional Mortality Estimates, heart disease and cancer remain the leading causes of death. For the 12-month period ending in the second quarter of 2024, the age-adjusted death rate for heart disease was 168.5 per 100,000 population, while cancer had a rate of 146.2 per 100,000.

Key players such as Merck Millipore, Sartorius AG, and Danaher Corporation are continuously investing in research and development to enhance filter performance, increase throughput, and comply with evolving industry standards. Strategic collaborations between pharmaceutical manufacturers and filtration technology providers are fostering innovation, enabling the development of customized filtration solutions tailored to specific drug formulations. The COVID-19 pandemic has underscored the critical role of pharmaceutical membrane filters in vaccine production and therapeutic drug manufacturing. The rising adoption of continuous manufacturing processes in the pharmaceutical sector is also fueling demand for high-efficiency membrane filtration systems that ensure consistent product quality and scalability.

The increasing government and private investments in the pharmaceutical and biotechnology industries are supporting the adoption of high-performance filtration technologies. For instance, in fiscal year 2023, the National Institutes of Health (NIH) received a budget of approximately US$ 47.7 billion, which included US$ 1.412 billion from Public Health Service (PHS) Evaluation financing, US$ 141.5 million in mandatory funding for the Special Type 1 Diabetes account, and US$ 1.085 billion allocated from the 21st Century Cures Act.

The expansion of biopharmaceutical research and increasing clinical trials in the US are expected to sustain the demand for membrane filters, particularly in sterile filtration and cell culture applications. Additionally, the growing focus on sustainability and eco-friendly filtration technologies is encouraging manufacturers to develop energy-efficient and recyclable membrane filtration products.

Advancements in Medical Cable Design to Provide Market trends in Future

The pharmaceutical industry in emerging markets, particularly India and China, is expanding rapidly, transforming these countries into global drug manufacturing hubs. Their competitive advantages-cost-effective production, skilled labor, favorable government policies, and growing domestic demand-are fueling large-scale pharmaceutical production. As a result, the need for advanced membrane filtration systems has surged, ensuring drug purity, regulatory compliance, and manufacturing efficiency.

India, often referred to as the "Pharmacy of the World," supplies over 20% of global generic drugs. With more than 3,000 pharmaceutical companies and 10,500 manufacturing facilities, many of which comply with international regulatory standards such as the US FDA and EMA, the country plays a critical role in the global supply chain. China, on the other hand, has made significant strides in biopharmaceuticals and active pharmaceutical ingredients (APIs), with strong government backing and regulatory reforms, such as the Marketing Authorization Holder (MAH) system, which has streamlined the drug manufacturing process. As both nations continue expanding their pharmaceutical exports, the demand for high-quality filtration technologies is growing to ensure compliance with global safety and quality standards.

Given the cost-sensitive nature of manufacturing in these markets, pharmaceutical companies are seeking membrane filtration solutions that balance efficiency with affordability; this has led to increased adoption of high-performance, scalable filtration systems that optimize production costs through reusable or single-use membranes, energy-efficient designs, and high-throughput filtration technologies. Government initiatives such as India's Production Linked Incentive (PLI) scheme and China's Made in China 2025 strategy support pharmaceutical self-sufficiency and encourage investments in advanced manufacturing capabilities. With rising exports to highly regulated markets such as the US and Europe, pharmaceutical firms in India and China must meet stringent filtration standards, further driving demand for cutting-edge membrane filtration solutions. The long-term growth of pharmaceutical manufacturing in these emerging economies is expected to sustain high demand for filtration technologies, supported by increasing healthcare needs, government incentives, and the rise of biosimilars and personalized medicine. As sustainability also becomes a priority, companies are shifting toward eco-friendly filtration systems that reduce waste, lower energy consumption, and enhance operational efficiency.

As India and China solidify their positions as global pharmaceutical powerhouses, advanced membrane filtration technologies will be instrumental in ensuring drug safety, quality, and cost efficiency; this presents a significant opportunity for both domestic and international membrane filter manufacturers looking to expand in these high-growth markets.

Some of the developments are:

To bolster domestic pharmaceutical manufacturing, the Indian government allocated close to US$3 billion under the PLI scheme for pharmaceuticals and medical devices. This initiative successfully attracted investments worth nearly US$4 billion as of April 2024.

India's pharmaceutical sector, valued at approximately USD 58 billion, is projected to reach US$ 120-130 billion by 2030 and US$ 400-450 billion by 2047. This growth is driven by factors such as the rising prevalence of lifestyle-related diseases, an aging population, and an increased focus on holistic health.

Between 2022 and 2025, Western pharmaceutical companies increasingly partnered with Chinese firms to access innovative "super me-too" drugs. Major companies such as GSK, Merck, and AstraZeneca entered into billion-dollar agreements to develop and market Chinese drugs internationally, leveraging China's expedited clinical trial processes.sss

In 2023, China and India achieved a record bilateral trade volume of US$136.2 billion, marking a 1.5% increase from the previous year. This growth was supported by a 6% rise in Indian exports to China, indicating strengthening economic ties between the two nations.

The World Health Organization, National Health of Health, and Organization for Economic Co-operation and Development are among the primary and secondary sources referred to while preparing the medical injection molding market report.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Pharmaceutical Membrane Filters Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Pharmaceutical Membrane Filters Market - Key Market Dynamics

5.1 Pharmaceutical Membrane Filters Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Demand for Biopharmaceuticals
- 5.2.2 Stringent Regulatory Requirements and Quality Assurance
5.3 Market Restraints
- 5.3.1 High Initial and Operational Costs
5.4 Market Opportunities
- 5.4.1 Technological Advancements in Membrane Filtration
5.5 Market Trends
- 5.5.1 Advancements in Medical Cable Design
5.6 Impact of Drivers and Restraints:

6. Pharmaceutical Membrane Filters Market - Global Market Analysis

6.1 Pharmaceutical Membrane Filters Market Revenue (US$ Million), 2021-2031
6.2 Pharmaceutical Membrane Filters Market Forecast Analysis

7. Pharmaceutical Membrane Filters Market Analysis - by Technology

7.1 Microfiltration
- 7.1.1 Overview
- 7.1.2 Microfiltration: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Ultrafiltration
- 7.2.1 Overview
- 7.2.2 Ultrafiltration: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Reverse Osmosis
- 7.3.1 Overview
- 7.3.2 Reverse Osmosis: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031
- 7.3.3 (US$ Million)
7.4 Nanofiltration
- 7.4.1 Overview
- 7.4.2 Nanofiltration: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)

8. Pharmaceutical Membrane Filters Market Analysis - by Design

8.1 Hollow Fiber
- 8.1.1 Overview
- 8.1.2 Hollow Fiber: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Spiral Wound
- 8.2.1 Overview
- 8.2.2 Spiral Wound: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Tubular System
- 8.3.1 Overview
- 8.3.2 Tubular System: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Plate and Frame
- 8.4.1 Overview
- 8.4.2 Plate and Frame: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)

9. Pharmaceutical Membrane Filters Market Analysis - by Material

9.1 Polyethersulfone (PES)
- 9.1.1 Overview
- 9.1.2 Polyethersulfone (PES): Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Polysulfone (PS)
- 9.2.1 Overview
- 9.2.2 Polysulfone (PS): Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Cellulose-Based Membranes
- 9.3.1 Overview
- 9.3.2 Cellulose-Based Membranes: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Polytetrafluoroethylene (PTFE)
- 9.4.1 Overview
- 9.4.2 Polytetrafluoroethylene (PTFE): Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Polyvinyl Chloride (PVC)
- 9.5.1 Overview
- 9.5.2 Polyvinyl Chloride (PVC): Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Polyacrylonitrile (PAN)
- 9.6.1 Overview
- 9.6.2 Polyacrylonitrile (PAN): Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)

10. Pharmaceutical Membrane Filters Market Analysis - by End User

10.1 Pharmaceutical and Biotech Industries
- 10.1.1 Overview
- 10.1.2 Pharmaceutical and Biotech Industries: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
10.2 CROs and CDMOs
- 10.2.1 Overview
- 10.2.2 CROs and CDMOs: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)

11. Pharmaceutical Membrane Filters Market - Geographical Analysis

11.1 Overview
11.2 North America
- 11.2.1 North America Pharmaceutical Membrane Filters Market Overview
- 11.2.2 North America: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
  - 11.2.2.1 North America: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Technology
  - 11.2.2.2 North America: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Design
  - 11.2.2.3 North America: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Material
  - 11.2.2.4 North America: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by End User
- 11.2.3 North America: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Country
  - 11.2.3.1 United States: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.3.1.1 United States: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.2.3.1.2 United States: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.2.3.1.3 United States: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.2.3.1.4 United States: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.2.3.2 Canada: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.3.2.1 Canada: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.2.3.2.2 Canada: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.2.3.2.3 Canada: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.2.3.2.4 Canada: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.2.3.3 Mexico: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.3.3.1 Mexico: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.2.3.3.2 Mexico: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.2.3.3.3 Mexico: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.2.3.3.4 Mexico: Pharmaceutical Membrane Filters Market Breakdown, by End User
11.3 Europe
- 11.3.1 Europe Pharmaceutical Membrane Filters Market Overview
- 11.3.2 Europe: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
  - 11.3.2.1 Europe: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Technology
  - 11.3.2.2 Europe: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Design
  - 11.3.2.3 Europe: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Material
  - 11.3.2.4 Europe: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by End User
- 11.3.3 Europe: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Country
  - 11.3.3.1 Germany: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.1.1 Germany: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.3.3.1.2 Germany: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.3.3.1.3 Germany: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.3.3.1.4 Germany: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.3.3.2 United Kingdom: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.2.1 United Kingdom: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.3.3.2.2 Kingdom: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.3.3.2.3 United Kingdom: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.3.3.2.4 United Kingdom: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.3.3.3 France: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.3.1 France: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.3.3.3.2 France: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.3.3.3.3 France: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.3.3.3.4 France: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.3.3.4 Italy: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.4.1 Italy: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.3.3.4.2 Italy: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.3.3.4.3 Italy: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.3.3.4.4 Italy: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.3.3.5 Spain: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.5.1 Spain: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.3.3.5.2 Spain: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.3.3.5.3 Spain: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.3.3.5.4 Spain: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.3.3.6 Rest of Europe: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.6.1 Rest of Europe: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.3.3.6.2 Rest of Europe: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.3.3.6.3 Rest of Europe: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.3.3.6.4 Rest of Europe: Pharmaceutical Membrane Filters Market Breakdown, by End User
11.4 Asia Pacific
- 11.4.1 Asia Pacific Pharmaceutical Membrane Filters Market Overview
- 11.4.2 Asia Pacific: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
- 11.4.3 Asia Pacific: Pharmaceutical Membrane Filters Market Breakdown, by Technology
  - 11.4.3.1 Asia Pacific: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Technology
  - 11.4.3.2 Asia Pacific: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Design
  - 11.4.3.3 Asia Pacific: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Material
  - 11.4.3.4 Asia Pacific: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by End User
- 11.4.4 Asia Pacific: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Country
  - 11.4.4.1 China: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.4.1.1 China: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.4.4.1.2 China: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.4.4.1.3 China: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.4.4.1.4 China: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.4.4.2 Japan: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.4.2.1 Japan: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.4.4.2.2 Japan: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.4.4.2.3 Japan: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.4.4.2.4 Japan: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.4.4.3 India: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.4.3.1 India: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.4.4.3.2 India: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.4.4.3.3 India: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.4.4.3.4 India: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.4.4.4 South Korea: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.4.4.1 South Korea: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.4.4.4.2 South Korea: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.4.4.4.3 South Korea: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.4.4.4.4 South Korea: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.4.4.5 Australia: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.4.5.1 Australia: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.4.4.5.2 Australia: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.4.4.5.3 Australia: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.4.4.5.4 Australia: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.4.4.6 Rest of APAC: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.4.6.1 Rest of APAC: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.4.4.6.2 Rest of APAC: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.4.4.6.3 Rest of APAC: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.4.4.6.4 Rest of APAC: Pharmaceutical Membrane Filters Market Breakdown, by End User
11.5 Middle East and Africa
- 11.5.1 Middle East and Africa Pharmaceutical Membrane Filters Market Overview
- 11.5.2 Middle East and Africa: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
  - 11.5.2.1 Middle East and Africa: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Technology
  - 11.5.2.2 Middle East and Africa: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Design
  - 11.5.2.3 Middle East and Africa: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Material
  - 11.5.2.4 Middle East and Africa: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by End User
- 11.5.3 Middle East and Africa: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Country
  - 11.5.3.1 South Africa: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.3.1.1 South Africa: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.5.3.1.2 South Africa: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.5.3.1.3 South Africa: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.5.3.1.4 South Africa: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.5.3.2 Saudi Arabia: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.3.2.1 Saudi Arabia: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.5.3.2.2 Saudi Arabia: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.5.3.2.3 Saudi Arabia: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.5.3.2.4 Saudi Arabia: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.5.3.3 United Arab Emirates: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.3.3.1 United Arab Emirates: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.5.3.3.2 United Arab Emirates: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.5.3.3.3 United Arab Emirates: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.5.3.3.4 United Arab Emirates: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.5.3.4 Rest of Middle East and Africa: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.3.4.1 Rest of Middle East and Africa: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.5.3.4.2 Rest of Middle East and Africa: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.5.3.4.3 Rest of Middle East and Africa: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.5.3.4.4 Rest of Middle East and Africa: Pharmaceutical Membrane Filters Market Breakdown, by End User
11.6 South and Central America
- 11.6.1 South and Central America Pharmaceutical Membrane Filters Market Overview
- 11.6.2 South and Central America: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
  - 11.6.2.1 South and Central America: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Technology
  - 11.6.2.2 South and Central America: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Design
  - 11.6.2.3 South and Central America: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Material
  - 11.6.2.4 South and Central America: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by End User
- 11.6.3 South and Central America: Pharmaceutical Membrane Filters Market - Revenue and Forecast Analysis - by Country
  - 11.6.3.1 Brazil: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.6.3.1.1 Brazil: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.6.3.1.2 Brazil: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.6.3.1.3 Brazil: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.6.3.1.4 Brazil: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.6.3.2 Argentina: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.6.3.2.1 Argentina: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.6.3.2.2 Argentina: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.6.3.2.3 Argentina: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.6.3.2.4 Argentina: Pharmaceutical Membrane Filters Market Breakdown, by End User
  - 11.6.3.3 Rest of South and Central America: Pharmaceutical Membrane Filters Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.6.3.3.1 Rest of South and Central America: Pharmaceutical Membrane Filters Market Breakdown, by Technology
    - 11.6.3.3.2 Rest of South and Central America: Pharmaceutical Membrane Filters Market Breakdown, by Design
    - 11.6.3.3.3 Rest of South and Central America: Pharmaceutical Membrane Filters Market Breakdown, by Material
    - 11.6.3.3.4 Rest of South and Central America: Pharmaceutical Membrane Filters Market Breakdown, by End User

12. Industry Landscape

12.1 Overview
12.2 Expansion
12.3 Collaboration
12.4 Merger and Acquisition
12.5 Partnerships
12.6 Other Business Strategies

13. Company Profiles

13.1 Thermo Fisher Scientific Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Merck KGaA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Danaher Corporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 3M
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Sartorius AG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Repligen Corporation
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Parker Hannifin Corporation
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Asahi Kasei Corporation
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 GEA Group
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Alfa Laval
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 TAMI Industries
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Membrane Solutions
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 Koch Industries
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
13.14 W L Gore and Associates Inc
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
- 13.14.6 Key Developments
13.15 Meissner Filtration Products, Inc.
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
- 13.15.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms